Panodil

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Panodil

Property Description
Active ingredient Acetaminophen (Paracetamol)
Pharmacological class Non-opioid analgesic and antipyretic
Origin Synthetic organic compound
Common purpose Symptomatic relief of pain and fever
Forms available Tablet, oral suspension, suppository

Is Panodil an Analgesic or an Antipyretic Medicine?

Panodil is a commonly known trade name for a medicinal preparation whose core component is the active substance Acetaminophen, an entity internationally recognized as Paracetamol. This substance belongs to the pharmacological class of non-opioid analgesics (pain relievers) and antipyretics (fever reducers), establishing its two fundamental roles in managing discomfort. The compound is a synthetic organic compound, distinguishing its chemical origin. It is essential to understand that while it provides relief from pain and fever, Acetaminophen is not structurally or functionally considered a Nonsteroidal Anti-inflammatory Drug (NSAID) because it lacks significant peripheral anti-inflammatory action at standard therapeutic doses. Paracetamol is recognized for its effectiveness and safety profile for these uses. Its primary purpose is, therefore, to provide targeted, symptomatic treatment.

What is the Active Ingredient in Panodil and How is it Formulated?

The definitive active ingredient within Panodil preparations is Acetaminophen, and the medicine is typically provided as a single-ingredient product, though combination formulations do exist. Panodil specifically differentiates its offering by focusing heavily on versatile formulations suitable for sensitive patient groups, such as the flavored oral suspension and the easily swallowed suppositories. This substance is formulated for several primary routes of administration, ensuring broad utility across various patient needs. The common dosage forms available include the familiar oral tablet, the quick-dissolving effervescent tablet, liquid oral suspension often used for children, and suppositories designed for rectal administration. Acetaminophen is the core agent for systemic relief in these diverse forms. This diverse range of forms, emphasized by the Panodil brand, ensures that the medicine is accessible and administrable to patients of nearly all age groups and physical states.

What is the General Purpose of Panodil?

The general purpose of Panodil is to offer fundamental and effective relief from two core types of physiological discomfort: pain and fever. For instance, it is commonly used for managing the discomfort associated with a common cold or reducing a temperature spike. By operating as an analgesic, it helps reduce the sensation of pain, and by acting as an antipyretic, it aids the body's mechanisms in lowering an elevated temperature. This makes its role central to the initial management of general aches, pains, and febrile states.

Regulatory References

  1. Paracetamol (acetaminophen) - eEML

What side effects are possible with Panodil?

Possible Side Effects and Safety Information

The active substance in Panodil (paracetamol) is generally well-tolerated at recommended therapeutic doses. However, the most critical safety concern is hepatotoxicity, or severe liver damage, which is dose-dependent and can be fatal, particularly in cases of acute overdose. Delayed, serious liver damage can occur even if initial symptoms are mild or absent, mandating immediate medical attention if an overdose is suspected.

Documented Adverse Reactions

Side effects are rare when Panodil is taken correctly. Adverse events reported from post-marketing experience include:

System/Organ Class Frequency Key Adverse Reactions
Immune System Rare to Not Known Hypersensitivity reactions (e.g., skin rash, itching, urticaria), anaphylactic shock, and angioedema.
Hepatobiliary Very Common in overdose Acute liver failure, severe liver damage. Abnormal liver function tests may occur with therapeutic use.
Blood and Lymphatic Not Known (Very Rare) Blood dyscrasias, including thrombocytopenia (low platelet count), agranulocytosis, and leucopenia.
Skin Very Rare Serious skin reactions, including Stevens–Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Acute Generalized Exanthematous Pustulosis (AGEP).

Safety Considerations and Restrictions

The hazard of liver damage is greater in patients with existing severe hepatic impairment or non-cirrhotic alcoholic liver disease. Caution is also advised for patients with severe renal impairment or those with glutathione depletion (e.g., chronic malnutrition, chronic heavy alcohol use), as this increases the risk of toxic liver reactions and high anion gap metabolic acidosis. Use is contraindicated in patients with a known allergy to paracetamol or any of the product's excipients.

Do not take any other medicines containing paracetamol while taking Panodil, and do not exceed the maximum recommended dose to mitigate the risk of potentially fatal liver damage.

Overdose and Emergency Response

The official regulatory profile for Panodil (Acetaminophen/Paracetamol) overdose outlines a severe, time-critical risk primarily involving the Hepatic System. The most serious potential outcome is severe hepatotoxicity, which can lead to acute liver failure, coagulation defects, metabolic abnormalities, and, ultimately, death. This toxicity is classified as life-threatening.

Immediate, mandatory action is required because an overdose may initially present with no symptoms (asymptomatic onset), or only non-specific early signs such as nausea, vomiting, or pallor. Liver injury signs, such as jaundice and abdominal pain, are typically delayed and appear when damage is already advanced.

Immediate medical attention must be sought for any suspected overdose, even if the individual appears well. Regulatory guidance emphasizes that quick intervention is critical. The specific antidote, N-acetylcysteine (NAC), is officially documented as the treatment. Its efficacy is time-sensitive, with maximal protection achieved if administered within the first eight hours of ingestion.

Management requires specific procedural steps, including obtaining serum acetaminophen concentration levels (at least four hours post-ingestion) and monitoring liver function (transaminases and INR) to predict risk and guide the duration of treatment. Individuals with pre-existing liver disease or chronic alcohol use are documented to have increased susceptibility to these toxic effects.

Therapeutic Uses of Panodil

What Panodil Treats: Main Uses and Benefits

Panodil (Acetaminophen/Paracetamol) is commonly used to help with symptoms related to physical discomfort, often applied across domains where additional symptomatic support is needed. It helps address symptom clusters that may become intense or disruptive, such as tension headaches, general muscle aches, toothaches, and menstrual pain. The symptomatic relief provided across these common discomforts contributes to easing the overall symptom load during periods of heightened symptoms and may assist with maintaining a sense of stability when symptoms are more noticeable.

This medication is also relevant in contexts marked by systemic imbalance and is commonly used across conditions presenting with acute or episodic manifestations, such as the common cold and influenza. It plays a role in managing elevated body temperature (fever), which is a symptom of increased physiological stress. Panodil is relevant when supportive symptom management is appropriate, as supporting the patient during difficult episodes by easing distress supports general well-being and supports patients during episodes of heightened discomfort.

“It is commonly used to address symptoms that interfere with daily comfort and create noticeable physiological strain.”

Quick Fact: Relief for Pain and Fever Panodil is applied in settings where symptoms become more noticeable, providing symptomatic assistance to manage both mild-to-moderate pain and fever in conditions characterized by periods of heightened symptoms.

Regulatory References

  1. NIH MedlinePlus

Eligibility and Restrictions for Use

Panodil (Acetaminophen/Paracetamol) eligibility is strictly defined by official regulatory documentation. The medicine is contraindicated for patients with a known hypersensitivity to the active ingredient or any formulation component. Use is also strictly prohibited for individuals diagnosed with severe hepatic impairment or severe active liver disease.

Beyond these absolute prohibitions, official labeling defines populations requiring restricted or conditional use. Caution is advised for patients with non-severe hepatic impairment, severe renal impairment (creatinine clearance le 30 mL/min), chronic alcoholism, chronic malnutrition, or severe hypovolemia. These conditions necessitate special consideration according to the regulatory profile.

Use is generally established for adults and adolescents. However, safety and effectiveness have not been established for some formulations in pediatric patients younger than 2 years of age. For pregnancy, use is permitted if clinically needed, provided it is at the lowest effective dose for the shortest possible duration. The medicine is generally considered not contraindicated during lactation.

What should I know about interactions with other medicines?

The interaction profile of Panodil (Acetaminophen/Paracetamol) is defined by regulatory bodies based on documented pharmacokinetic and pharmacodynamic effects with other substances.

Contraindicated Combinations

Co-administration with any other medicine containing Acetaminophen or Paracetamol is officially prohibited by regulatory agencies to prevent accidental overdose and severe liver toxicity.

Documented Pharmacokinetic Interactions

Interaction Type Interacting Substance(s) Regulatory Finding
Clearance Reduction Probenecid Reduces Panodil clearance by inhibiting conjugation [SmPC].
Toxicity Risk Increase Enzyme Inducers (e.g., Phenytoin, Carbamazepine, Rifampicin, St John's Wort) Increases the potential for hepatotoxicity via accelerated toxic metabolite formation [FDA, SmPC].
Absorption Rate Metoclopramide/Domperidone Increases the speed of Panodil absorption [SmPC].
Absorption Rate Colestyramine Reduces the speed of Panodil absorption [SmPC].

Documented Pharmacodynamic Interactions

Warfarin and Coumarins: Prolonged regular daily use is documented to enhance the anticoagulant effect, increasing the risk of bleeding. This requires heightened monitoring of INR values [FDA, SmPC].

Flucloxacillin: Co-administration has been officially linked to reports of High Anion Gap Metabolic Acidosis (HAGMA) [SmPC].

Timing and Population Notes

The absorption interaction with Colestyramine requires that it should not be taken within one hour of Panodil when rapid effect is sought. Furthermore, the risk of serious liver damage from Panodil is officially noted to be increased in patients with risk factors for glutathione depletion or those with underlying severe hepatic impairment, who are generally contraindicated for its use.

Mechanism of Action

How Panodil Works

Panodil, containing paracetamol (acetaminophen), exerts its primary mechanistic effects within the central nervous system (CNS) through multiple, interconnected pathways.

Modulation of Central Prostaglandin Synthesis

This domain involves the drug's selective action on the cyclooxygenase (COX) enzyme system, mainly in the brain and spinal cord. Paracetamol functions as a weak inhibitor of COX, reducing the synthesis of prostaglandins, which are lipid mediators that promote enhanced physiological responses. This interaction results in the overall modulation of heightened physiological responses within the CNS.


Bioactive Metabolite Signaling Cascade

The drug initiates a cascade where it is metabolized in the CNS into AM404. This metabolite interacts with specific receptors, including the Transient Receptor Potential Vanilloid-1 (TRPV1) receptor. This binding event modulates the dynamic equilibrium of cellular signaling within targeted pathways, leading to specific intracellular consequences and system-level physiological modulation.


Descending Serotonergic Pathway Activity

Panodil additionally influences systems where specific neurotransmitters dominate by affecting the descending inhibitory serotonergic pathway in the spinal cord. This enhances the pathway's inhibitory signaling sequences, which modulates the influence of elevated mediator activity and modifies early molecular steps that shape systemic physiological outcomes.

Dosage and Administration Information

Panodil (Acetaminophen/Paracetamol) administration is strictly defined by regulatory guidelines, focusing on precise dosing and administration procedures.

Administration Routes and Schedules

Approved routes of administration include oral (tablet, suspension, effervescent), rectal (suppository), and intravenous (IV) infusion. The standard adult dosing regimen specifies a single dose of 500 mg to 1,000 mg, with a mandated minimum interval of four hours between administrations. The maximum total daily dose from all sources in 24 hours must not exceed 4,000 mg; however, some regional guidelines enforce a lower 3,000 mg limit.

Preparation and Procedural Constraints

The medicine can be taken with or without food. Administration of oral powder or effervescent formulations requires full dissolution in water before ingestion. Intravenous preparations must be administered slowly as an infusion, with a duration of no less than 15 minutes. Patients are strictly prohibited from using this medicine in combination with any other product that also contains paracetamol or acetaminophen.

Population-Specific Adjustments

Population-specific adjustments are required based on physiological status. For adults weighing under 50 kg, the maximum daily dose is typically reduced. For patients with severe renal impairment, the minimum dosing interval must be extended to six or eight hours to prevent accumulation. The medication is designated for short-term use only, and administration for pain or fever should not exceed three to five days without clinical re-evaluation.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Panodil

Evidence for Symptomatic Relief of Fever (Antipyresis)

Research exploring how symptoms change over time in individuals with elevated temperatures heavily relies on short-term Randomized Controlled Trials (RCTs) and comprehensive meta-analyses. These studies monitored patients, including Adults, Children, and Infants, during acute periods of fever, often linked to infections. Studies reported measurements of a decline in body temperature from the starting elevated point, and research indicates that these changes were measured within a short timeframe, usually within the first 4 to 24 hours of administration.

What remains uncertain is that the evidence provides limited insight into long-term physiological outcomes related to fever observation beyond the initial acute period. Additionally, research so far indicates that while the short-term outcomes have been measured, the data are still emerging when comparing the measured effect across all diverse underlying causes of fever.

Evidence for Acute Pain Management

The evidence base for acute, mild-to-moderate physical discomfort is extensive, consisting mainly of single-dose and short-term RCTs, which are then compiled in systematic reviews. This research focused on conditions involving periods of heightened symptoms, such as tension headaches, dental pain, and post-operative discomfort, enrolling populations of Adults and Adolescents. Trials reported patterns where a measured change in pain intensity occurred in the short term, often within 30 to 60 minutes of dosing in the specific pain models studied.

However, the results apply only to the populations studied in the research, and there is limited information for outcomes beyond a 48-hour period for most acute pain models. Furthermore, the measured variables were observed to vary notably based on the specific type, location, and initial severity of the pain examined in the trials.

Long-Term Evidence and Follow-up Duration in Research

The majority of pivotal studies that establish the primary symptomatic research domains of Panodil involve short-term follow-up durations, typically hours to days, which is consistent with its role in addressing acute or episodic changes. Studies designed to observe responses over more extended periods (weeks to months) are primarily conducted to examine what was observed regarding tolerability during continuous use, rather than to specifically track the long-term, sustained outcomes of the symptomatic measures.

Data for certain groups remain insufficient regarding outcomes related to the sustained observation of ongoing pain patterns over periods longer than 12 weeks. Research on long-term effects regarding continuous symptomatic use is not fully established, and evidence for maintenance in chronic conditions is described as being inconsistent.

Key Studies & References

  1. The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews
  2. Incidence of side effects associated with acetaminophen in people aged 65 years or more: a prospective cohort study
  3. Public Assessment Report Scientific discussion Paracetamol pxgpharma 500 mg film-coated tablets (EMA/national agency document)
  4. Analgesia guidelines for acute pain management in adults (NHS Scotland/Local Guideline Reference)

Frequently Asked Questions (FAQ)

Common questions about Panodil (FAQ)

Q: How quickly does Panodil typically start working?

A: Official information indicates that after oral administration, the active ingredient typically reaches its peak concentration in the body within 30 to 60 minutes. This time frame is associated with peak concentrations, which is when the medicine's effect is generally measured.

Q: How long can the effects of Panodil last?

A: Regulatory guidelines specify a minimum interval of four hours between administrations. This interval relates to the medicine’s expected duration of action.

Q: Can Panodil be used by children?

A: Official labeling indicates the active ingredient is established for use in children and infants. Use of the medicine requires specific dosage instructions and maximum limits that are detailed in official labeling based on age and weight.

Q: Is Panodil considered safe to use during pregnancy or while breastfeeding?

A: Official information describes the active ingredient as an option for pain relief under these conditions. Use is permitted when clinically needed, provided it is at the lowest effective dose for the shortest possible duration.

Q: What happens if someone accidentally takes Panodil more frequently than advised?

A: Regulatory labeling strictly advises adherence to the minimum interval between doses and the maximum daily limit. Exceeding recommended use increases the risk of severe liver damage, known as hepatotoxicity.

Q: Does alcohol consumption affect how Panodil works?

A: Official warnings state that alcohol use increases the potential for severe liver damage when using this medicine, especially in those who consume three or more alcoholic drinks daily. Individuals in this group are advised to consult a healthcare professional.

Q: Is Panodil safe to take if I have kidney issues?

A: Regulatory documents note that the presence of severe renal impairment requires specific adjustments to the minimum time between doses. This adjustment is necessary to prevent accumulation of the medicine in the body.

Q: Does Panodil interfere with laboratory blood tests?

A: Acetaminophen is described as potentially interfering with the results of certain laboratory tests. This may include tests that monitor blood glucose levels or liver enzymes.

Q: Is Panodil used for headaches only, or does it help with other types of pain?

A: Regulatory indications include relief of various types of mild-to-moderate pain, not just headaches. This includes backache, muscular aches, and discomfort associated with dental procedures.

Q: Does taking Panodil affect sleep?

A: Official documents have reported adverse effects on the nervous system, including dizziness, and psychiatric effects, such as restlessness and insomnia (difficulty sleeping). The frequency of these effects is generally described as not known or rare.

Q: Can Panodil be taken on an empty stomach?

A: Administration procedures state that the medicine may be taken with or without food.

Q: What are the signs of a serious allergic reaction to Panodil?

A: Regulatory information states that signs of a serious reaction can include sudden swelling of the face, throat, or lips, and difficulty breathing. Other signs may involve a rash, hives, or peeling and blistering of the skin.

Q: Are there any long-term safety concerns associated with Panodil use?

A: The medicine is designated for short-term symptomatic relief only. Guidelines advise that use for pain or fever should not exceed three to five days without professional re-evaluation, due to potential risks that may be associated with use exceeding the designated short-term duration.

Q: Is there a maximum number of days Panodil should be taken consecutively?

A: The medication is designated for short-term use and guidelines advise limits on consecutive days of use. Administration for pain or fever should not exceed three to five days without professional re-evaluation.

Q: What does 'contraindication' mean in the context of Panodil?

A: A contraindication is a regulatory term used to describe a specific condition or circumstance that makes the use of a medicine strictly prohibited. This is because using the medicine in that situation carries a documented risk of causing harm.

Q: Why is Panodil often mentioned in relation to dental pain?

A: Official labeling documents include the temporary relief of pain associated with toothache and dental procedures as a registered indication.

Q: What does 'therapeutic dose' mean when discussing Panodil?

A: 'Therapeutic dose' refers to the recommended amount of the medicine defined by regulatory authorities. This is the amount intended to provide the desired symptomatic effect while minimizing the risk of adverse reactions.

Q: Is there a risk of becoming dependent on Panodil?

A: Regulatory classifications place the active ingredient in the non-opioid analgesic class. This class of medicine is not associated with the risks of physical dependence seen with opioid-class medicines.

Q: Can I take Panodil if I have a history of ulcers?

A: The medicine is not classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). It lacks the significant peripheral anti-inflammatory action associated with the gastrointestinal risk commonly associated with NSAIDs.

Q: Is it normal to feel a slight stomach upset after taking Panodil?

A: Gastrointestinal reactions, including nausea, vomiting, and epigastric discomfort (upper stomach discomfort), have been reported in official adverse event documents. However, these events are generally described as not known or rare.

Q: Why is Panodil sold under different brand names globally?

A: The active substance is known internationally by two names: Acetaminophen (used primarily in the US) and Paracetamol (used elsewhere). This distinction leads to a variety of brand names globally, all approved by different national regulatory bodies.

Q: Why is Panodil sometimes combined with other active ingredients in medications?

A: The active ingredient is approved for use in combination formulations alongside other active substances. This is typically done to address multiple symptoms simultaneously, as regulated by official product licenses.

Q: Are there any reported interactions between Panodil and caffeine?

A: Official information does not typically list a direct interaction between the single-ingredient medicine and caffeine. However, caffeine is frequently included as an approved ingredient in combination formulations for headache relief.

Q: Does Panodil have research backing its use for migraines?

A: Yes, research-based indications documented by regulatory bodies include the temporary symptomatic relief of pain associated with migraine headaches.

Q: What is the specific timing required if taking Panodil with Colestyramine?

A: The regulatory information on interactions states that Colestyramine should not be taken within one hour of this medicine when a rapid effect is desired. Colestyramine is known to reduce the speed of the medicine's absorption.

Q: Is Panodil known to cause drowsiness?

A: Official adverse event reports for the single active ingredient do not typically list drowsiness as a common or known side effect. However, related effects such as dizziness have been reported.

How should Panodil be stored and disposed of?

How to Store and Dispose of Panodil

The storage and disposal of Panodil (paracetamol) must adhere strictly to official regulatory guidelines to maintain product quality and ensure safety.

Storage Requirements

Item Requirement
Temperature Range Store at 20 C to 25 C (68 F to 77 F); avoid excessive heat (above 40 C) and do not freeze.
Protection Keep in the original package to protect from light and moisture.
Child Safety Must be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused Panodil must be disposed of according to local requirements. Regulatory guidelines advise against flushing the medicine down the toilet. The preferred method is using a drug take-back program. If unavailable, mix the medicine with an undesirable substance (such as dirt) in a sealed container and throw it into the household trash, ensuring all personal information is removed from the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Panodil found in:

A-Z Index: